Curriculum Vitae
Dong Wook Nathan Kim, M.D. Ph.D.
BOARD CERTIFICATION:
American Board of Radiology, Radiation Oncology 2007
LICENSURE
Active License - Texas and Missouri
PROFESSIONAL EXPERIENCE
8/2011-Present
University of Texas Southwestern Medical Center
Department of Radiation Oncology
Assistant Professor
11/2009-7/2011
The Center for Cancer and Blood Disorders, Fort Worth, TX
Staff Radiation Oncologist, Medical Director for Radiation Oncology
Departments (Burleson and Weatherford Campus)
7/2006-11/2009
St. John’s Cancer Center, Springfield, MO
Section Chair, Department of Radiation Oncology
7/2006-5/2009
St. John’s Cyberknife Radiosurgery Center, Springfield, MO
Co-Medical Director, Radiosurgery Center
2006-2009
Member, Executive Board, Cancer Research of the Ozarks (CCOP)
Springfield, MO
2006-2009
St. John’s Member, Steering Committee, Cancer Research of the Ozarks
(CCOP), Springfield MO, July 2006-2009
2006-2009
St. John’s Physician Liaison Committee Member
ACS-SJCC Community Partnership, Springfield, MO
FACULTY APPOINTMENTS
11/2005-7/2006
Vanderbilt University Medical Center, Nashville, Tennessee
Research Instructor, Department of Radiation Oncology
EDUCATION AND TRAINING
-1-
7/2002-7/2006
Vanderbilt University Medical Center, Nashville, Tennessee
Chief Resident, Department of Radiation Oncology, 2004 - 2005
Resident Department of Radiation Oncology, 7/2002 – 7/2006
7/2001-6/2002
Vanderbilt University Medical Center, Nashville, Tennessee
Intern, Department of Internal Medicine, 7/2001-6/2002
1993-2001
Boston University School of Medicine, Boston, Massachusetts:
M.D./PhD. (Ph.D. in Biochemistry)
1991-1993
Johns Hopkins University, Baltimore, Maryland:
Master of Science in Biomedical Engineering
1987-1991
University of Michigan, Ann Arbor, Michigan:
Bachelor of Science in Electrical Engineering
Magna Cum Laude
RESEARCH
2006 – 2010
Department of Radiation Oncology, St. John’s Cancer Center
Characterization of PET data to assess for tumor response to Cyberknife
Stereotactic Body Radiotherapy
2003- 2006
Department of Radiation Oncology, Vanderbilt University School of
Medicine, Mentor - Dr. Dennis Hallahan
 Preclinical analysis of EGFR/VEGFR inhibition in combination with external
beam radiation therapy as a therapeutic targeted strategy in prostate cancer
 Proteomic analysis of lung and prostate cancer to predict response to tyrosine
kinase inhibitor and radiation therapy
 Tumor response imaging with DCE MRI and Ultrasound
 Targeting the aerobic glycolytic pathway for cancer therapy
 Pharmacodynamics of response to vasculytic therapy in prostate, and lung
cancer preclinical models
2004 – 2006
Department of Radiation Oncology, Vanderbilt University School of
Medicine, Mentor - Dr. Bapsi Chak, Associate Professor and Director of GI
Section
 Mature analysis of patients treated with tri-modality therapy for locally
advanced esophageal cancer (phase II study, GI-22)
2002- 2003
Department of Radiation Oncology, Vanderbilt University School of
Medicine, Mentor - Dr. Hak Choy, Professor, Department of Radiation
Oncology
-2-


Long term follow-up of three paclitaxel- based phase II concurrent
chemo/radiation trials for locally advanced non-small cell lung cancer
(LANSCLC)
The role of tumor responsiveness as a predictor for long term survival in
LANSCLC patients treated with paclitaxel based concurrent chemo/radiation.
1995 – 1999
Department of Biochemistry, Boston University School of
Medicine, Graduate Student, Mentor - Dr. Gail E. Sonenshein
 Investigation of the role of NF-B/Rel, c-myc , AhR, and p27Kip1 in the
etiology and progression of breast cancer
1991-1993
Eisenhower Research Center, Applied Physics Laboratory, Graduate
Student, Mentor - Dr. Isaac N. Bankman
 Image processing and pattern recognition algorithms and code development
for early detection of breast cancer using digitized mammograms
1991
Medison Co. Ltd., Research and Development Division
 Development of a data generation code which implements dynamic
apodization and dynamic aperture concepts in ultrasound imaging
1990
Department of Radiology, University of Michigan Medial
Center, Summer Research Assistant, Advisor - Dr. H. P. Chan
 Edge enhancement and detection algorithm development for automated
analysis of digitized bone-hand radiographs
FELLOWSHIPS/GRANTS
St. John’s Cancer Center, Springfield MO
2007
Cyberknife Society Grant - $9,100 in support of research activity (1 yr)
Vanderbilt University medical Center, Nashville, TN
2004-2007
Research Fellowship, Prostate Cancer, Department of Defense-$150,000 in
support of research activities (2 yrs)
2004-2005
RSNA Holman Pathway Research Resident Seed Grant $30,000 in direct support
of research activities (1 yr)
2004
VARIAN Grant for Grand Rounds/Visiting Professorship Series, $10,000 (1 yr)
2005
Genentech Grant for Grand Rounds/Visiting Professorship Series, $5,000 (1 yr)
2005
Aventis-Sanofi Grant for Visiting Professorship Series, $5,000 (1 yr)
2005
Lilly and Co. Grant to support Visiting Professorship Series, $4,000 (1 yr)
Boston University School of Medicine, Boston, MA
1998
Graduate Student Research Fellowship (BUSM, 1 yr)
1998-2000
Department of Defense Predoctoral Fellowship (Breast Cancer Research, 2 yrs)
1997
Grunebaum Fellowship for Cancer Research (BUSM, 1 yr)
1996
Medical Student Research Fellowship, American Heart Association (1 yr)
-3-
1994
Paul and Helen Mitchell Scholarship
Johns Hopkins University, Baltimore, MD
1992-94
Applied Physics Laboratory, Masters Student Fellowship for Biomedical
Engineering (2 yrs)
University of Michigan, Ann Arbor, MI
1990
Biomedical Engineering Summer Research Fellowship, University of Michigan
HONORS
2009
ASTRO 2009 – Poster Discussion
2009
Cyberknife Society Meeting 2009 – Oral Presentation
2007
Cyberknife Society Meeting 2007 - Oral Presentation
2005
RSNA 2005 - Resident Trainee Award and Travel Grant
2005
RSNA 2005 - Oral Presentation
2005
4th Annual NCI-RRP/ROSP Young Investigators Workshop for Radiation Oncology
Residents Travel Grant Award
2005
ASTRO Translational Symposium 2005, Poster Award Winner
2005
ASTRO Translational Symposium 2005, Travel Grant
2005
Vanderbilt Ingram Cancer Center Annual Retreat, Most Outstanding Poster Award
Recipient (1st place)
2005
AACR AFLAC Scholars in Training Award, 2005 (Top abstracts from junior scientists)
2005
Oral Presentation at AACR 2005
2005
Award Winner, Vanderbilt University 23rd Annual Research Forum
2004
Two Oral Presentations, ASTRO 2004
2004
ASTRO 2004 Basic Science Travel Grant Recipient
2004
Oral Presentation, and Award Winner, KASTRO essay contest
2004
Award Winner, Vanderbilt University 22nd Annual Research Forum (Clinical Science)
2001
Sidney Cooperband Award (research excellence in medical school), Boston University
School of Medicine
1999
Award Winner, Department of Biochemistry, Russek Graduate Student Achievement
Day: Boston University School of Medicine
1996
Honorable Mention, Howard Hughes Medical Institute Predoctoral Fellowship
1993
Master Student Research Award: Johns Hopkins University
1989
Tau Beta Pi Honor Society: University of Michigan
1989
Angell Scholar: University of Michigan
1988
William J. Branstrom Freshman Prize: University of Michigan
1987-90 Deans List, and Honor Student: University of Michigan
INVITED LECTURES
2007
“New developments in Radiation Oncology”, Women’s forum, St. John’s Cancer
Center, Springfield, MO
2006
“ Radiation Oncology and Radiosurgery ” Dine with the Docs, St. John’s Cancer
Center, Springfield, MO.
2005
“Assessment of physiologic response to radiation-mediated tumor vasculature
-4-
2005
2005
directed therapy: implications for treatment optimization”, presented at Department of
Radiation Oncology, University of Pennsylvania, Philadelphia, PA, December 6, 2005
“Assessment of physiologic response to radiation-mediated tumor vasculature
directed therapy: implications for treatment optimization”, presented at Department of
Radiation Oncology, University of Alabama, Birmingham, AL, December 14, 2005
"Radiation-mediated strategies for damaging the tumor vasculature", presented at
Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida,
December 19, 2005
TEACHING EXPERIENCE
2010
Clinical Preceptor, UNT Health Science Center (PA/medical students)
2002-04
Instructor, Introduction to Clinical Oncology for Medical Physics Vanderbilt
University Medical Center
 Fundamentals of clinical radiation oncology - semester course for Medical
Physics student
1997
Teaching Assistant, Boston University Medical Center
 Biochemistry laboratory class for first year medical students
1997
Tutor, Boston University Medical Center
 Biochemistry course for first year medical students
MISCELLANEOUS EXPERIENCE
2005-2006
Reviewer, International Journal of Radiation Oncology, Biology, Physics
2004-2005
Chief Resident, Vanderbilt University Medical Center Department of
Radiation Oncology
1998-1999
Voting Member, M.D./PhD. Admission Committee, Boston University
School of Medicine
1997-1998
Assistant Editor, CANSWERS (Cancer prevention and control student
newsletter for Boston University School of Medicine)
Spring 1990
Rehabilitation Engineering Laboratory, University of Michigan Medical
Center, Dr. Simon Levine - Engineering rehabilitation devices for patients
1988-1991
Freshman Engineering Lab, University of Michigan Grader and Assistant:
FORTRAN, Introduction to Digital Computers
MEMBERSHIPS
2002-present
Member, American Society of Therapeutic Radiation Oncology (ASTRO)
2006-present
Member, Cyberknife Society
2005-2006
Member, Radiation Research Society (RRS)
2004-2006
Member, American Association Cancer Research (AACR)
2004-present
Member, Korean-ASTRO
2002-present
Member, American Society Clinical Oncology (ASCO)
1999
Member, Massachusetts Medical Society
1996
Member, American Association for the Advancement of Science
1995
Founder and President Asian American Medical Association, Boston
University School of Medicine Chapter
-5-
PUBLICATIONS:
1.
J. Huamani, C. Willey, D. Thotala, K. J. Niermann, M. E. Reyzer, L. Leavitt, C. Jones,
A. Fleishcher, R. M. Caprioli, D. E. Hallahan, D.W. Kim (corresponding author).
Differential efficacy of combined therapy with radiation and AEE788 in androgen
independent prostate tumors with high or low EGFR expression levels. May 1;71(1):23746. Epub 2008 March 11.
2.
D.W.Kim, J.Huamani, K.J. Niermann, H. Lee, L. Geng, L.L. Leavitt, R.A. Baheza, C.C.
Jones, S. Tumkur, T.E. Yankeelov, A.C. Fleischer, D.E. Hallahan. Non-invasive
Assessment of Tumor Vasculature Response to Radiation-Mediated Vasculature Targeted
Therapy Using Quantified Power Doppler Ultrasonography: Implications for Therapy
Schedule Optimization. J. Ultrasound Med. 2006, Dec; 25(12): 1507-17.
3.
K.J. Niermann, A.C. Fleischer, J. Huamani, T.E. Yankeelov, D.W. Kim, W.D. Wilson,
D.E. Hallahan. Measuring tumor perfusion in control and treated murine tumors:
correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced
magnetic resonance imaging and fluorodeoxyglucos positron emission tomography. J.
Ultrasound Med. Jun; 26(6): 749-756, 2007.
4.
D.W. Kim, Blanke, CD, Wu, H., Shyr, Y., Berlin, J., Beauchamp, D., Chakravarthy, B.
Phase II Study of Preoperative Paclitaxel/cisplatin with Radiotherapy in Locally
Advanced Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 8.
5.
D.W. Kim, J. Huamani, A. Fu, D.E.Hallahan. Molecular strategies targeting the host
component of cancer to enhance tumor response to radiation therapy. International
Journal of Radiation Oncology, Biology, Physics. Jan 1;64(1):38-46, 2006.
6.
D.W. Kim, Y. Shyr, B. Shakthour, W.L. Akerley, D.H. Johnson, H. Choy. Long-term
Follow Up and Analysis of Long Term Survivors in Patients Treated with PaclitaxelBased Concurrent Chemo/Radiation Therapy for Locally Advanced Non-Small Cell Lung
Cancer. Lung Cancer, Nov,50(2):235-45, 2005.
7.
D.W. Kim, Y. Shyr, H. Chen, W.L. Akerley, D.H. Johnson, H. Choy. Response to
Combined Modality Therapy Correlates with Survival in Locally Advanced Non-Small
Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, Nov
15;63(4):1029-36, 2005.
8.
Yankeelov TE, Niermann KJ, Huamani J, Kim DW, Quarles CC, Fleischer AF, Hallahan
DE, Price R, Gore GC. Correlation Between Estimates of Tumor Perfusion from
Microbubble Contrast Enhanced Sonography and Dynamic Contrast Enhanced Magnetic
Resonance Imaging. Journal of Ultrasound Medicine J Ultrasound Med. 2006
Apr;25(4):487-97, 2006.
9.
L. Geng, E.T. Shinohara, D. W. Kim, J. Tan, K. Osuski, Y. Shyr, D.E. Hallahan. Tumor
Pharmacodynamic Response to PDGFR Inhibition Correlates with Cytotoxic Effects in
Preclinical Glioblastoma Models. International Journal of Radiation Oncology, Biology,
Physics, Jan 1;64(1):263-71, 2006.
10.
D.W. Kim, H. Choy. Potential role for epidermal growth factor receptor inhibitors in
combined-modality therapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys.
2004;59(2 Suppl):11-20
11.
H. Choy and D.W. Kim. Rationale for Investigation of Epidermal Growth Factor
Receptor Inhibitors in Definitive Treatment of Locally Advanced Non-Small Cell Lung
-6-
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Cancer and Head and Neck Cancer. Seminars in Respiratory and Critical Care Medicine
2004; 25: 33-43
D.W. Kim and H. Choy. Combined Modality Therapy for Non-Small Cell Lung Cancer,
Past, Present, and Future. Lung Cancer 42 Suppl 2:S35-40, 2003.
R. Romieu-Mourez, D.W. Kim(co-first author), S. M. Shin, E. Landesman-Bollag, D.
C. Seldin, R. D. Cardiff, and G. E. Sonenshein. MMTV-c-rel Transgenic Mice Develop
Mammary Tumors. Mol Cell Biol. Aug;23(16):5738-54, 2003.
D.W. Kim, B. Lu, D.E. Hallahan. Receptor tyrosine kinase inhibitors as anti-angiogenic
agents. Current Opinion in Investigational Drugs, Jun;5(6):597-604, 2004
B. Lu, D.W. Kim, D.E. Hallahan. Tumor angiogenesis as a strategy for radiosensitization.
Invited Manuscript to Cancer Therapy, Dec; 1: 335, 2003
H. Choy, D. W. Kim. Chemotherapy and Irradiation Interaction. Semin Oncol. 2003
Aug;30(4 Suppl 9):3-10.
D. W. Kim, L. Gazourian, S. A. Quadri, R. Romieu-Mourez, D. H. Sherr, G. E.
Sonenshein. The RelA NF-B Subunit and the Aryl Hydrocarbon Receptor (AhR)
Cooperate to Transactivate the c-myc Promoter in Mammary Cells. Oncogene 19(48):
5498-5506, 2000.
D.W. Kim, M.A. Sovak, G. J. Zanieski, G. Nonet, R. Romieu-Mourez, A.W. Lau, L.J.
Hafer, P. Yaswen, M. Stampfer, J. Russo, A.E. Rogers, G.E. Sonenshein. Activation of
NF-B/Rel Occurs Early During Neoplastic Transformation of Mammary Cells.
Carcinogenesis 21(5): 871-879, 2000.
A.F. Trombino, R.I. Near, R.A. Matuika, S. Yang, L.J. Haefer, P.I. Toselli, D.W. Kim,
A.E. Rogers, G.E. Sonenshein, D.H. Sherr. Expression of Aryl Hydrocarbon
Receptor/Transcription Factor (AhR) and AhR-Regulated CYP1 Gene Transcripts in a
Rat Model of Mammary Tumorigenesis. Breast Cancer Res Treat 63(2):117-31, 2000
M.A. Sovak, R.E. Bellas, D.W. Kim, G.J. Zanieski, A.E. Rogers, A.M. Traish, G.E.
Sonenshein. Aberrant Nuclear Factor-B/Rel Expression and the Pathogenesis of Breast
Cancer. Journal of Clinical Investigation 100(12):2952-2960. Dec. 1997.
W.Yang, J.Shen, M.Wu, M. Arsura, M. Fitzgerald, Z. Suldan, D.W. Kim, C.S.Hofmann,
S. Pianetti, R. Romieu-Mourez, L.P. Freedman, G.E. Sonenshein. Repression of
Transcription of the p27Kip1 Cyclin-Dependent Kinase Inhibitor Gene by c-Myc.
Oncogene 20(14):1688-702, March 2001.
K. T. Kavanagh, L. J. Hafer, D. W. Kim, K. K. Mann, D. H. Sherr, A. E. Rogers, and G.
E. Sonenshein. Green Tea Extracts Decrease Carcinogen-Induced Mammary Tumor
Formation In Vivo and Breast Cancer Cell Proliferation in Culture via Induction of
p27Kip1 Cyclin-Dependent Kinase Inhibitor. J Cell Biochem 82(3):387-98, 2001.
ORAL PRESENTATIONS/POSTER DISCUSSION:
1.
D.W. N. Kim, J. Robertson, M. Barnes, R. Sonnemaker, F. Schmidt, H. Kim, L. Stanek.
Poster Discussion, ASTRO 2009. Standard Uptake Value (SUV) Measurement From
CT/PET Scans Following Stereotactic Body Radiotherapy Correlates With The Biologically
Effective Dose (BED) Delivered
2.
D.W. Kim, J. Robertson, M. Barnes, R. Sonnemaker, S. Long, D. Frieda, K. Dootson, H.
Kim, F. Schmidt, A. Scarrow, L. Stanek. Quantitative SUV measurements derived from
analysis of CT/PET scans of lung tumors at multiple time intervals following Cyberknife
-7-
3.
4.
5.
6.
7.
8.
9.
radiosurgery therapy correlates with Biologically Effective Dose (BED) delivered.
Cyberknife Users Meeting February 2009.
D.W. Kim, F. Schmidt, , H. Kim, R. Sonnemaker, S. Long, M. Albritton, C. Hunt, D.Frieda,
M. Barnes, K. Dootson, M.Bakry, J.Alford, A.Scarrow. Characteristics of short interval
CT/PET data following cyberknife radiosurgery for lung cancer patients concerning for
disease persistence. Cyberknife Society Users Meeting, January 2007
D.W. Kim, M.L. Reyzer, J. Huamani, K. J. Niermann, R. Caprioli, D.E. Hallahan. Direct
Analysis of Protein Markers of Therapeutic Response in Tumors Treated with Radiation and
Receptor Tyrosine Kinase Inhibitors (TKI) by Imaging Mass Spectrometry. RSNA 2005.
D.W. Kim, M.L. Reyzer, J. Huamani, K.J. Niermann, T.E. Yankeelov, S. Tumkur, L. Geng,
H. Lee, R. Baheza, R. Caprioli, D.E. Hallahan. Improved Tumor Control by Schedule
Optimization of Radiation-Mediated Vasculytic Therapy Based on Non-Invasively
Measured Physiologic Parameters. AACR 2005.
D.W. Kim, M.L. Reyzer, J. Huamani, K.J. Niermann, T.E. Yankeelov, S. Tumkur, L. Geng,
H. Lee, R. Baheza, R. Caprioli, D.E. Hallahan. Improved Tumor Control by Schedule
Optimization of Radiation-Mediated Vasculytic Therapy Based on Non-Invasively
Measured Physiologic Parameters. Vanderbilt University Resident Research Forum Award
Winner, Basic Science Category 2005.
D.W. Kim, L. Geng, K. Niermann, H.Lee, D.E. Hallahan. Pharmacodynamics of Tumor
Response to Tyrosine Kinase Inhibitors of VEGF Receptors. Oral Presentation #33, ASTRO
2004. International Journal of Radiation Oncology, Biology, Physics. Vol 60(1) Supplement:
S148, 2004
D.W. Kim, A. Fu, K. Niermann, J. Kaminski, D.E. Hallahan., Rapid Assessment of Cancer
Susceptibility to TKIs by Use of Phage-Displayed Peptide Libraries. Oral Presentation, #75,
ASTRO 2004. International Journal of Radiation Oncology, Biology, Physics. Vol 60(1)
Supplement: S175, 2004
D.W. Kim, W.L. Ackerley, Y. Shyr, D.E. Hallahan, H. Choy. COMBINED MODALITY
THERAPY (CMT) USING CONCURRENT RADIATION THERAPY (RT) WITH
PACLITAXEL BASED CHEMOTHERAPEUTIC REGIMEN IN LOCALLY ADVANCED
NONSMALL CELL LUNG CANCER (LANSCLC): LONG TERM FOLLOW UP AND
ANALYSIS OF LONG TERM SURVIVORS. Vanderbilt University Resident Research
Forum, Award Winner, Clinical Science Category, 2004.
ABSTRACTS / POSTER PRESENTATIONS:
1.
2.
3.
4.
A. Pinheiro, N. Kim, H.Kim. Stereotactic radiosurgery for Head and Neck and Skull base
Cancer., S356, 7th International Conference on Head and Neck Cancer
A. Scarrow, C. Hunt, H. Kim, D.W. Kim. Cyberknife Radiosurgery for Trigeminal
Neuralgia. Cyberknife 6th Annual Users Meeting, 2007.
D.W. Kim, J. Huamani, M. Reyzer, D. Mi, R. M. Caprioli, D. E. Hallahan. Imaging Mass
Spectrometry to Map Distribution of Radiation Enhancing Vasculature Targeted Drug and
Protein Biomarkers of Response to Therapy in Prostate Cancer. Poster Presentation, ASTRO
2006.
J. Huamani, K. Niermann, C.Willey, M. E. Reyzer, D. Thotala, L. Leavitt, C. Jones, A.
Fleishcher, R. M. Caprioli, D. E. Hallahan, D.W. Kim. EGFR Activity Determines the
-8-
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Efficacy of Combined Therapy with Radiation and AEE788 in Prostate Cancer. Poster
Presentation, ASTRO 2006.
D.W. Kim, M.L. Reyzer, J. Huamani, K. J. Niermann, T.E. Yankeelov, S. Tumkur, L. Geng,
H. Lee, R. Baheza, R. Caprioli, D.E. Hallahan. Radiotherapeutic Schedule Optimization For
Targeting Tumor Vasculature: Implications of Non-invasive Physiologic Imaging. ASTRO
2005.
J. Huamani, K.J. Niermann, M.L. Reyzer, J. Alberts, C. Jones, R. Caprioli, D.E. Hallahan,
D.W. Kim. Combination Therapy of Ionizing Radiation with AEE788, a Dual Receptor
Tyrosine Kinase Inhibitor Targeting Epidermal Growth Factor Receptor (EGFR) and
Vascular Endothelial Growth Factor Receptor (VEGFR) Leads To Improved Tumor Control.
Poster Discussion, ASTRO 2005.
D.W. Kim, M. Reyzer, J. Huamani, K. Niermann, S. Tumkur, L. Geng, H. Lee, R. Baheza,
R. Caprioli, D.E. Hallahan. Physiologic parameters of response to radiation mediated tumor
vasculytic therapy can be used to optimize schedule of administration of cytotoxic therapy.
Radiation Oncology Gordon Conference, 2005.
Mamatha Rao, Kalyani Kasisomayajula, Reid Thompson, Dennis Hallahan, Dong Kim,
Ling Geng, John Gore, Thomas Yankeelov, Michelle Reyzer, Richard Caprioli, Nagendra
Ningaraj. Study of Proteomic and BBB Permeability Changes in Brain Tumor, AACR 2005.
Niermann, K.J., Fleischer, A.C., Kim, D.W., Huamani, J., Yankeelov, T.E., Hallahan, D.E.
Microbubble Enahanced Oncologic Sonography – Assessment of Treatment Response.
American Institute of Ultrasound in Medicine, June 2005, Orlando, Florida, USA
H. Choy, D. W. Kim, W. L. Akerley, H. Safran, Y. Shyr, A. T. Turrisi, S. Graziano, T.
Kennedy, D. H. Johnson. Combined modality therapy (CMT) using concurrent radiation
therapy with paclitaxel based chemotherapeutic regimen in unresectable locally advanced
non-small cell lung cancer; long term follow-up on three sequential multi-institutional
prospective phase II studies. Poster Discussion, Abstract # 2564, ASCO 2003.
D.W. Kim, Y. Shyr, W. L. Akerley, H. Choy. Tumor responsiveness to combined modality
therapy (CMT) IS highly significant predictor of survival for patients with Locally Advanced
Non-Small Cell Lung Cancer (LANSCLC). Abstract P-589, 10th World Conference on Lung
Cancer. Lung Cancer 41(Supp2): 239, 2003.
D.W. Kim, W.L. Akerley, Y. Shyr, H. Choy. Combined modality therapy (CMT) using
concurrent radiation therapy with paclitaxel based chemotherapeutic regimen in locally
advanced non-small cell lung cancer: long term follow-up and analysis of long term
survivors. Abstract P-588, 10th World Conference on Lung Cancer. Lung Cancer 41(Supp2):
240, 2003.
D.W. Kim, Y. Shyr, W.L. Akerley, H. Choy. Combined Modality Therapy (CMT) Using
Concurrent Radiation Therapy (RT) with Paclitaxel Based Chemotherapy in Locally
Advanced NonSmall Cell Lung Cancer (LANSCLC): Long Term Follow Up and Analysis
of Long Term Survivors. 22nd Annual Resident Research Forum, Oral Presentation, Clinical
Research Category, May 2004.
D.W. Kim, M.A. Sovak, G. Zanieski, A. Lau, L.Gazourian, S. A. Quadri, R. RomieuMourez, G. Nonet, L.J. Haefer, P. Yaswen, M. Stampfer, J. Russo, A. E. Rogers, P. Toselli,
D. Sherr, and G. E. Sonenshein. Role of NF-B/Rel, Ahr, and c-myc in breast cancer. DOD
ERA OF HOPE MEETING, 2000.
-9-
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
W. Yang, J. Shen, Stefania Pianetti, M. FitzGerald, M. Arsura, M. Wu, Z. Suldan, R.
Romieu-Mourez, D.W. Kim, H. Lee, L. P. Freedman, and G. E. Sonenshein. Repression of
the transcription of the p27kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene
meeting 2000.
Raphaëlle Romieu-Mourez, D.W. Kim, M.A. Sovak, G. Zanieski, A.W. Lau, L.J. Hafer,
A.E. Rogers, E. Landesman-Bollag, D.C. Seldin, J. Russo, and G.E. Sonenshein. NFB/Rel Activation in Breast Cancer Occurs Early and is Mediated by Aberrant Kinase
Activity. Oncogene meeting 2000.
D.W. Kim, M.A. Sovak, M. Arsura, G. J. Zanieski, K. Kavanagh, G. Nonet, P. Yaswen, M.
Stampfer, J. Russo, A.E. Rogers, G.E. Sonenshein. Early Activation of NF-B/Rel During
Neoplastic Transformation of Mammary Cells. Russek Day, Boston University.
M.A. Sovak, D.W. Kim, G.J. Zanieski, A.E. Rogers, A.M. Traish, D.H. Sherr, G.E.
Sonenshein. Mechanism of Aromatic Hydrocarbon Induced Mammary Tumorigenesis. The
Department of Defense Breast Cancer Research Program Meeting, Era of Hope.
Proceedings Volume II, p. 499, 1997.
M. A. Sovak, D.W. Kim, A. M. Traish, G.E. Sonenshein. Constitutive NF-B/Rel
Expression in Breast Epithelial Tumor Cell Lines and Primary Breast Tumor Tissue.
Journal of Cellular Biochemistry 18D, 219-54, 1994.
I.N. Bankman, W.A. Christens-Barry, D.W. Kim, I.N. Weinberg, O.B. Gatewood, and
W.R. Brody. Algorithm for Detection of Microcalcification Clusters in Mammograms. Proc.
of 15th Annual International Conference, IEEE Engineering in Medicine and Biology
Society(EMBS), 1993.
I.N. Bankman, W.A. Christens-Barry, D.W. Kim, I. N. Weinberg, O.B. Gatewood, and
W.R. Brody. Automated Recognition of Microcalcification Clusters in Mammograms. Proc.
of SPIE Biomedical Image Processing IV Conference, pp. 731-738, Vol. 1905,February,
1993.
I.N. Bankman, D.W. Kim, W.A. Christens-Barry, I.N. Weinberg, O.B. Gatewood, and W.R.
Brody. Automated System for Early Breast Cancer Detection in Mammograms. Proc. of
NASA, Technology 2002 Conference, pp. 77-85, Vol. 1, 1992.
I.N. Bankman, W.A. Christens-Barry, I.N. Weinberg, D.W. Kim, R.D. Semmel, and W.R.
Brody. An Algorithm for Early Breast Cancer Detection in Mammograms. Proc. 5th IEEE
Symposium on Computer Based Medical Systems(CBMS), pp. 362-369, 1992.
I.N. Bankman, W.A. Christens-Barry, I.N. Weinberg, R.F. Brem, D.W. Kim, and W.R.
Brody. Automated Detection of Microcalcification Clusters in Mammograms. Proc.6th
Symposium for Computer Assisted Radiology, pp. 137-143,1992.
-10-